Annual Accounts Receivable
$7.44 M
+$6.09 M+450.59%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual accounts receivable is $7.44 million, with the most recent change of +$6.09 million (+450.59%) on December 31, 2022.
Performance
IMPL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$6.59 M
-$215.00 K-3.16%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly accounts receivable is $6.59 million, with the most recent change of -$215.00 thousand (-3.16%) on September 1, 2023.
- Over the past year, IMPL quarterly accounts receivable has increased by +$457.00 thousand (+7.46%).
Performance
IMPL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IMPL Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +450.6% | +7.5% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
IMPL Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -81.8% | -11.5% | -79.5% |
| 5 y | 5-year | at high | -100.0% | -11.5% | -100.0% |
| alltime | all time | at high | -100.0% | -11.5% | -100.0% |
Impel Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $6.59 M(-3.2%) |
| Jun 2023 | - | $6.80 M(+8.3%) |
| Mar 2023 | - | $6.28 M(-15.6%) |
| Dec 2022 | $7.44 M | $7.44 M(+21.5%) |
| Sep 2022 | - | $6.13 M(+27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $4.79 M(+23.4%) |
| Mar 2022 | - | $3.89 M(+187.4%) |
| Dec 2021 | $1.35 M(>+9900.0%) | $1.35 M(+37.8%) |
| Sep 2021 | - | $981.00 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Impel Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual accounts receivable year-on-year change?
- What is Impel Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Impel Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of IMPL is $7.44 M
What is the all time high annual accounts receivable for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual accounts receivable is $7.44 M
What is Impel Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, IMPL annual accounts receivable has changed by +$6.09 M (+450.59%)
What is Impel Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of IMPL is $6.59 M
What is the all time high quarterly accounts receivable for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly accounts receivable is $7.44 M
What is Impel Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, IMPL quarterly accounts receivable has changed by +$457.00 K (+7.46%)